Results 91 to 100 of about 850,964 (168)

Why didn't the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder? [PDF]

Aust N Z J Psychiatry, 2023
Rossell SL, Meikle SE, Williams ML, Castle DJ.   +3 more
europepmc   +1 more source

Community interest survey findings: 2022 report

, 2022
A survey to better understand community interest in accessing psilocybin services, in applying for licensure for one of the four license types, and in training program approval.

core  

Psilocybin and ayahuasca in treatment-resistant depression: clinical evidence, methodological constraints and ethical challenges: a narrative review

Frontiers in Psychiatry
BackgroundTreatment-resistant depression (TRD) is a major clinical challenge, with many patients failing to respond to conventional antidepressants. Psychedelic compounds such as psilocybin and ayahuasca have recently gained attention as potential rapid ...
Serena Chiara Civardi, Filippo Besana, Federico Durbano, Marco Otto Maria Toscano, Fabiola Raffone, Fabiola Raffone, Bernardo Maria Dell’Osso, Bernardo Maria Dell’Osso, Bernardo Maria Dell’Osso, Bernardo Maria Dell’Osso, Miriam Olivola   +10 more
doaj   +1 more source

Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis

Journal of Psychedelic Studies
Abstract Background and Aims Psilocybin-assisted psychotherapy (PAP) is a novel, transdiagnostic treatment in which the 5-HT2A receptor agonist psilocybin is combined with psychotherapy. Studies to date have evaluated PAP's effects on depression, substance use, and end-of-life adjustment ...
Alex Hood, Gary Elkins
openaire   +1 more source

Is there mush-room to improve the environmental sustainability of psilocybin production?

Journal of CO2 Utilization
Mental health disorders and associated economic impact continue to rise domestically and globally. In 2023, to expand treatment options for individuals suffering Treatment Resistant Depression (TRD), the Therapeutic Goods Administration (TGA) of ...
Luke Lanham, Alistair McTaggart, James R. Falconer   +2 more
doaj   +1 more source

Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics

Psychoactives
Psychedelic treatments are emerging as promising interventions for many mental health conditions. These interventions are not offered in a standardized fashion across studies and between different healthcare centers.
Mathieu Fradet
doaj   +1 more source

The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy

Journal of Scientific Exploration, 2023
openaire   +1 more source

Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer. [PDF]

ACS Pharmacol Transl Sci, 2021
Ross S, Agin-Liebes G, Lo S, Zeifman RJ, Ghazal L, Benville J, Franco Corso S, Bjerre Real C, Guss J, Bossis A, Mennenga SE.   +10 more
europepmc   +1 more source

Oregon Psilocybin Advisory Board rapid evidence review and recommendations

, 2021
authors: the Oregon Psilocybin Evidence Review Writing Group, Atheir I. Abbas, MD, PhD, Angela Carter, ND, Thomas Jeanne, MD, MPH, Rachel Knox, MD, MBA, P.

core  

Older Adults in Psychedelic-Assisted Therapy Trials: A Systematic Review

European Psychiatry
Introduction Growing clinical interest in psychedelic-assisted therapies has led to a second wave of research involving psilocybin, LSD, MDMA and other substances.
L. Bouchet, Z. Sager, A. Yrondi, N. Kabir, B. Anderson, S. Ross, P. Petridis, Y. Beaussant   +7 more
doaj   +1 more source